Back
Ares Capital Vs. Belite Bio Industry Stock Comparison
Buy
56
ARCC
Ares Capital
Last Price:
22.15
Seasonality Move:
1.62%
Buy
89
BLTE
Belite Bio
Last Price:
63.72
Seasonality Move:
11.16%
Buy
56
Ares Capital (ARCC)
is a Buy
Is Ares Capital a Buy, Sell or Hold?
- The current Ares Capital [ARCC] share price is $22.15. The Score for ARCC is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- ARCC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
89
Belite Bio (BLTE)
is a Buy
Is Belite Bio a Buy, Sell or Hold?
- The current Belite Bio [BLTE] share price is $63.26. The Score for BLTE is 89, which is 78% above its historic median score of 50, and infers lower risk than normal.
- BLTE is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ARCC Stock Price Chart
What is Ares Capital's stock price today?
-
The Ares Capital share price today is $22.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARCC is experiencing slight buying pressure.
BLTE Stock Price Chart
What is Belite Bio's stock price today?
-
The Belite Bio share price today is $63.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLTE is experiencing selling pressure, which indicates risk of future bearish movement.
ARCC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.21 | Buy |
| Relative Strength Index (14 RSI): | 70.34 | Buy |
| Chaikin Money Flow: | 825153 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.25 - 21.91) | Buy |
| Bollinger Bands (100): | (20.57 - 21.51) | Buy |
BLTE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.34 | Buy |
| Relative Strength Index (14 RSI): | 37.56 | Sell |
| Chaikin Money Flow: | -29972 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (67.4 - 82.56) | Sell |
| Bollinger Bands (100): | (44.53 - 68.23) | Buy |
ARCC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.95 | Buy |
| 20-day SMA: | 21.61 | Buy |
| 50-day SMA: | 21.33 | Buy |
| 200-day SMA: | 20.87 | Buy |
| 8-day EMA: | 21.94 | Buy |
| 20-day EMA: | 21.72 | Buy |
| 50-day EMA: | 21.42 | Buy |
| 200-day EMA: | 20.84 | Buy |
BLTE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 74.7 | Sell |
| 20-day SMA: | 77.14 | Sell |
| 50-day SMA: | 63.91 | Sell |
| 200-day SMA: | 50.1 | Buy |
| 8-day EMA: | 71.95 | Sell |
| 20-day EMA: | 73.47 | Sell |
| 50-day EMA: | 66.83 | Sell |
| 200-day EMA: | 52.56 | Buy |
Ares Capital Earnings Growth & ARCC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.14 per share.
Belite Bio Earnings Growth & BLTE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and an increase next year of $0.18 per share.
Ares Capital Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Belite Bio Technical Analysis
| Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||